INOVIO PHARMACEUTICALS INC's ticker is and the CUSIP is 45773H951. A total of 2 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 1,300 | -35.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 2,000 | -62.3% | 0.00% | – |
| Q1 2023 | $4 | -94.3% | 5,300 | -88.2% | 0.00% | – |
| Q4 2022 | $70 | -99.9% | 45,000 | -13.8% | 0.00% | – |
| Q3 2022 | $90,000 | +23.3% | 52,200 | +23.7% | 0.00% | – |
| Q2 2022 | $73,000 | -77.7% | 42,200 | -53.9% | 0.00% | – |
| Q1 2022 | $328,000 | -56.6% | 91,500 | -39.6% | 0.00% | -100.0% |
| Q4 2021 | $755,000 | -67.4% | 151,500 | -38.2% | 0.00% | -50.0% |
| Q3 2021 | $2,319,000 | +2.2% | 245,200 | +0.2% | 0.00% | 0.0% |
| Q2 2021 | $2,268,000 | – | 244,700 | +12019.9% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 2,019 | -40.4% | 0.00% | -100.0% |
| Q4 2020 | $2,997,000 | -34.9% | 3,387 | -14.7% | 0.00% | -33.3% |
| Q3 2020 | $4,604,000 | -76.6% | 3,969 | -45.7% | 0.01% | -80.6% |
| Q2 2020 | $19,700,000 | +755.0% | 7,310 | +136.0% | 0.03% | +675.0% |
| Q1 2020 | $2,304,000 | +3616.1% | 3,098 | +1539.2% | 0.00% | – |
| Q4 2019 | $62,000 | +82.4% | 189 | +13.9% | 0.00% | – |
| Q3 2019 | $34,000 | +142.9% | 166 | +232.0% | 0.00% | – |
| Q2 2019 | $14,000 | -33.3% | 50 | -12.3% | 0.00% | – |
| Q1 2019 | $21,000 | +950.0% | 57 | +1040.0% | 0.00% | – |
| Q4 2018 | $2,000 | -60.0% | 5 | -66.7% | 0.00% | – |
| Q2 2018 | $5,000 | +25.0% | 15 | -80.0% | 0.00% | – |
| Q1 2018 | $4,000 | -80.0% | 75 | -25.0% | 0.00% | -100.0% |
| Q4 2017 | $20,000 | +100.0% | 100 | -29.6% | 0.00% | – |
| Q3 2017 | $10,000 | -23.1% | 142 | -76.7% | 0.00% | -100.0% |
| Q2 2017 | $13,000 | +1200.0% | 610 | +2950.0% | 0.00% | – |
| Q1 2017 | $1,000 | -80.0% | 20 | -85.5% | 0.00% | – |
| Q4 2016 | $5,000 | +25.0% | 138 | -23.3% | 0.00% | – |
| Q3 2016 | $4,000 | -60.0% | 180 | -4.8% | 0.00% | -100.0% |
| Q2 2016 | $10,000 | +42.9% | 189 | +6.2% | 0.00% | 0.0% |
| Q1 2016 | $7,000 | -75.0% | 178 | +10.6% | 0.00% | -50.0% |
| Q4 2015 | $28,000 | -58.8% | 161 | -55.0% | 0.00% | -60.0% |
| Q3 2015 | $68,000 | +195.7% | 358 | +106.9% | 0.01% | +150.0% |
| Q2 2015 | $23,000 | -47.7% | 173 | -0.6% | 0.00% | -60.0% |
| Q1 2015 | $44,000 | +18.9% | 174 | -1.1% | 0.01% | +25.0% |
| Q4 2014 | $37,000 | – | 176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 363,200 | $3,578,000 | 0.06% |
| Citadel Advisors | 16,400 | $162,000 | 0.00% |